ROBERT SMYTHE: Open Payments
NPI 1306874607 · YUMA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 32 payments from 10 companies in 2025. Trend: 2023 $733 · 2024 $574 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $192 |
| Lilly USA, LLC | 5 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Amgen Inc. | 4 | $68 |
| Boston Scientific Corporation | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Novo Nordisk Inc | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: UBRELVY, QULIPTA, MOUNJARO, AIRSUPRA, OTEZLA, WaveWriter Alpha Prime 16, VARIVAX, Repatha.
Industry payments across AZ — which companies pay providers there.
